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Background: Various flavonoids obtained from the genus Cirsium have been reported to exhibit beneficial effects
on health. The present study evaluated the antiobesity effects of Cirsium brevicaule A. GRAY leaf (CL) by using
3T3-L1 cells and C57BL/6 mice that were fed a high-fat diet (HFD).
Methods: Dried CL powder was serially extracted with solvents of various polarities, and these extracts were tested
for antiadipogenic activity using 3T3-L1 adipocytes. Mice were fed experimental HFD supplemented with dried CL
powder for 4 wk. Lipid levels and mRNA levels of genes related to lipid metabolism were determined in 3T3-L1
adipocytes and the white adipose tissue (WAT) and liver of mice fed on a HFD.
Results: Treatment of 3T3-L1 adipocytes with a hexane extract of CL significantly reduced cellular lipid
accumulation and expression of the fatty acid synthase (FASN) gene. Dietary CL reduced the serum levels of non-
esterified fatty acids in HFD-fed mice. Significant decreases in subcutaneous WAT weight and associated FASN gene
expression were observed in the mice fed the experimental CL diet. Dietary CL also reduced the hepatic lipid and
serum levels of a hepatopathic indicator in the HFD-fed mice. A significant reduction in mRNA levels of FASN and
HMG-CoA reductase were observed in the livers of the CL-diet group. Dietary CL, on the other hand, increased in
the hepatic mRNA levels of genes related to β-oxidation, namely peroxisome proliferator-activated receptor α,
calnitine palmitoyltrasferase 1A, and uncoupling protein 2. Expression of the insulin receptor gene was also
significantly increased in the livers of mice-fed the CL diet.
Conclusions: The present study therefore demonstrated that CL suppresses lipid accumulation in the WAT and
liver partly through inhibiting mRNA levels of FASN gene and enhancing the lipolysis-related gene expression.
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Obesity, a natural consequence of over-nutrition and
irregular living habits, contributes to the pathogenesis
of metabolic syndrome. Metabolic syndrome, which
comprises a cluster of metabolic abnormalities such as
hyperlipidemia, type 2 diabetes mellitus (T2DM), and
hypertension, is a widespread and an increasingly preva-
lent disease in industrialized countries, and it has contrib-
uted to an increase in cardiovascular morbidity and
mortality [1,2]. Nonalcoholic fatty liver disease (NAFLD)
is also often associated with metabolic syndrome [3,4].
Several therapeutic agents have been developed for
treating obesity by reducing nutrient absorption [5] or by* Correspondence: okuhiros@comb.u-ryukyu.ac.jp
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reproduction in any medium, provided the orenhancing thermogenesis and lipid turnover [5,6]. How-
ever, practical use of these drugs has been hampered by
their side effects and because of the rebound weight,
which is gained upon termination of these therapies. In
this context, it has been considered that supplementation
of the daily diet with natural anti-obesity agents would be
effective for managing obesity, as well as calorie control
and exercise. From viewpoint of safety, the medicinal
plants and their active compounds merit investigation for
development of natural antiobesity agents.
During recent decades, many studies reported the
beneficial effects of flavonoids on health, and these effects
were either dependent or independent of their antioxidant
activities. Increasing evidence indicates that flavonoid-rich
food, beverages, and extracts, as well as pure flavonoids,
could ameliorate the symptoms of metabolic syndromeLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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been isolated as naturally occurring compounds from the
genus Cirsium [8,9]. It was reported that pectolinarin
and 5,7-dihydroxy-6,4’-dimethoxyflavone (DDMF) iso-
lated from C. japonicum DC inhibits the growth of im-
planted tumors and promotes innate immunity in mice
[10]. Further, these studies showed that flavonoids en-
hance the adipocyte differentiation and glucose uptake
in 3T3-L1 cells [11] and demonstrated the antidiabetic
activities of pectolinarin and DDMF in rats in which
diabetes was induced by streptozotocin and a high-
carbohydrate/high-fat diet [12]. The crude extracts of C.
oligophyllum reduced the weight of subcutaneous and
visceral white adipose tissue (WAT) weights in rats [13].
A significant hypoglycemic effect of C. pascuarense was
shown in alloxan-induced diabetes [14]. C. brevicaule A.
GRAY (CBAG), which is a wild perennial herb, grows in
rocky gravels or forest margins along maritime coast-
lines [15], and is distributed in southern-Japan and
Taiwan. Its leaves, stems and roots are traditionally used
as not only a food stuff but also as herbal medicine in
the Okinawa Islands and Amami Islands of Japan. How-
ever, no scientific data on the biological activities of CBAG
are available. We therefore evaluated the biological activ-
ities of CBAG pertaining to metabolic syndrome. This
study aimed to characterize the CBAG leaf (CL) as an
antiobesity agent by testing its activities in vitro tissue cul-
tures and an in vivo animal model.
Materials and methods
Preparation of CBAG leaf powder and extracts
The CBAG that was used in this study was harvested on
Tokunoshima Island in Kagoshima Prefecture, Japan. The
freeze-dried and ground powder of CL was generously
provided by Tokunoshima-cho (Kagoshima, Japan). The
CL powder was analyzed by Japan Food Research Labora-
tories (Tokyo, Japan) and the nutrient composition was
found to be as follows: carbohydrate, 12.7%; fiber, 37.8%;
mineral 19.9%; protein, 19.1%; fat, 5.3%; and moisture,
5.2%. The dried-CL powder was serially extracted by incu-
bation with 10 volumes of hexane, chloroform, ethanol
and water for 2 h at 37°C. The filtrates were evaporated or
freeze-dried in vacuo, and stored at −80°C until use. The
dried extracts were dissolved in dimethyl sulfoxide at
25 mg/mL and filter-sterilized before use. The total phen-
olic contents of the serial extracts from the CL were mea-
sured using the Folin-Denis assay method as previously
reported [16]. The phenolic contents were expressed in
chlorogenic acid equivalents (mg CA/g extract).
Cell culturing and treatment
3T3-L1 preadipocytes were purchased from the American
Type Culture Collection (VA, USA). 3T3-L1 cells were
maintained in DMEM containing 10% calf serum at 37°Cin a humidified atmosphere of 5% CO2. Complete conflu-
ence of the cells was avoided before initiating differenti-
ation. For adipogenesis, confluent cells were maintained
for another 2 d. And then differentiation was induced
with standard differentiation procedure for 2 d in the
presence of the CL extracts as mentioned previously
[17]. The cells were re-fed with DMEM containing 10%
FBS supplemented with 10 μg/mL human insulin and
50 μg/mL CL extract for 4 d. Cell viability was measured
using MTS assay to test the cytotoxic effects of the
treatment on the 3T3-L1 cells.Measurement of lipid accumulation in cultured
adipocytes
To evaluate the effect of each CL extract on lipid accu-
mulation, the cultured 3T3-L1 cells were stained with
Oil Red O using a standard protocol, and their lipid drop-
lets were observed under a microscope. Cellular lipid was
extracted and purified by using the method of Bligh and
Dyer [18], and intracellular triglyceride (TG) content was
quantified using a commercial enzymatic kit as described
below. The cellular protein content was determined using
a Quant–iT protein assay kit (Life technologies, CA, USA).Animals and experimental diets
All procedures for the animal experiments were per-
formed in conformance with the guidelines on animal
experiments provided set out by the ethical committee
of the Animal Welfare Center at the University of the
Ryukyus. Eighteen 3-wk-old male C57BL/6 (B6) mice
were purchased from Japan SLC, Inc. (Shizuoka, Japan).
The mice were housed individually in plastic cages
under specific pathogen-free conditions, and maintained
at 24°C in a 12 h light–dark cycle. After 1 wk of adapta-
tion, the B6 mice were randomly divided into 3 experi-
mental HFD groups (n = 6 for each group): a control
diet group, a 5% CL diet group, and a 10% CL diet group.
Experimental HFD containing with 15% fat were prepared
on the basis of AIN-76 formulation—its composition is
summarized in Table 1. Approximately 31% of total calo-
ries were derived from fat in HFD used in this study. We
prepared the HFD expeditiously in room temperature.
Prepared HFD were stored at −80°C in plastic bags with
nitrogen gas until use. The mice were fed the experimen-
tal HFD and water ad libitum for 4 wk. At the end of the
feeding period, the mice were killed after 6 h starvation by
exsanguination from the heart under anesthesia induced
using pentobarbital sodium salt. Their liver and epididy-
mal, perirenal, omental and waist subcutaneous WATs
were excised and serum was separated from the blood.
Liver, perirenal and subcutaneous WATs, and sera were
frozen immediately in liquid nitrogen and then were
stored at −80°C until use.
Table 1 Composition of the experimental diets
Ingredient Diet
Control 5% CL 10% CL
(%)
Casein 20 19.045 18.09
β-Corn starch 15 14.365 13.73
Sucrose 39.4 38.485 37.49
Cellulose 5 3.11 1.22
Mineral mix (AIN-76) 3.5 3.5 3.5
Vitamin mix (AIN-76) 1 1 1
DL-Methionine 0.3 0.3 0.3
Choline bitartrate 0.2 0.2 0.2
Corn oil 15 14.735 14.47
Water 5.2 2.6 0.0
CL powder* 0 5 10
Total 100 100 100
*Carbohydrate, 12.7%; fiber, 37.8%; mineral 19.9%; protein, 19.1%; fat, 5.3%;
moisture, 5.2%.
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Serum levels of TG, total cholesterol (TC), and non-
esterified fatty acids (NEFA) were determined by using a
commercial enzymatic kit (Wako Pure Chemical Indus-
tries, Ltd., Osaka, Japan). The activities of aspartate ami-
notransferase (AST) and alanine aminotransferase (ALT)
in serum were measured by using a commercially available
kit (Wako Pure Chemical Industries, Ltd.) Serum levels of
insulin and total adiponectin were measured by using
ELISA kits that were purchased from Morinaga Institute
of Biological Science, Inc. (Kanagawa, Japan) and Otsuka
Pharmaceutical Co., Ltd. (Tokyo, Japan), respectively.
Measurement of TG and TC levels in the liver
Hepatic lipids were extracted and purified according to a
method reported previously [19]. Hepatic TG and TC
levels were determined by using the method of Fletcher
[20] and by using a commercial enzymatic kit as men-
tioned above, respectively.
RNA extraction and quantitative real-time RT-PCR
Total RNA was extracted from the cultured cells or the ex-
cised tissues by using TRIzol Reagent and a PureLink RNA
mini kit (Life technologies). First strand cDNA was synthe-
sized with 2 μg of total RNA as a template. The Additional
file 1: Table S1 lists the DNA sequences of specific primers
that were used for quantitative real-time PCR: β-actin, 18S
rRNA, mesoderm-specific transcript (MEST), peroxisome
proliferator-activated receptor (PPAR) α, PPARγ, sterol
regulatory element-binding protein (SREBP)-1c, SREBP-2,
fatty acid binding protein 4 (FABP4), CCAAT/enhancer
binding protein (C/EBP) α, fatty acid synthase (FASN),
insulin receptor (IR), HMG-CoA reductase (HMGCR),calnitine palmitoyltrasferase (CPT)-1A, insulin induced
gene (INSIG)-2a, acyl-CoA oxidase (AOX), and uncoup-
ling protein (UCP)-2. The amplifications were performed
in a commercial real-time PCR system (StepOne Real-
Time PCR System; ABI). The relative amount of each gene
transcript was normalized to the amount of β-actin tran-
script in adipocytes and WAT and to the amount of 18S
rRNA in the liver.
Statistical analysis
For in vitro experiments, the statistical significance of
the difference between two experimental groups was de-
termined by using Student’s t-test. The statistical signifi-
cance of the differences between the mean values of the
control and treatment groups were inspected by using
Dunnett’s test for the animal experiments. Differences
were considered significant at P < 0.05.
Results
Phenolic content of CL extracts
Serial extractions of CL powder were performed to
evaluate their effectiveness in vitro. The yields of the dry
material from extracts were as follows (g/100 g CL pow-
der): hexane extract (1.97 g), chloroform extract (2.73 g),
ethanol extract (7.33 g) and water extract (28.8 g). Of
these extracts, the ethanol extract had the highest phen-
olic content (618 mg CA/g). The phenolic content of
hexane, chloroform, and water extracts were 26.4, 70.9,
and 121 mg CA/g extract, respectively.
Effect of CL extracts on 3T3-L1 adipocytes
The antiadipogenic activities of serial extracts from CL
were tested in vitro by using Oil Red O staining
(Figure 1A). Red-stained lipid droplets in differentiated
adipocytes were not observed in the non-differentiated
3T3-L1 cells (Figure 1A). Adipogenic differentiation of
the 3T3-L1 cells significantly increased their lipid con-
tent (Figures 1A and 1B). No significant effect on the
lipid content of 3T3-L adipocytes was noted with the
chloroform, ethanol, or water extracts of CL powder
(Additional file 1: Table S2). However, lipid droplet for-
mation was significantly less in the cells treated with
the CL hexane extract than in the control cells. The CL
extracts did not affect the cell viability of the differenti-
ated 3T3-L1 adipocytes (data not shown).
Effect of CL hexane extracts on gene expression in 3T3-L1
adipocytes
To gain more insight into the effects of the CL hexane
extract on lipid metabolism, we examined the gene
expression of 3T3-L1 adipocytes that were harvested on
day 4 of differentiation. The expressions of all of genes
that were determined in this study were enhanced by the
induction of adipogenesis (Figure 2). Of these, increases
Figure 1 Effects of Cirsium brevicaule A. GRAY leaf (CL) extracts on lipid accumulation in 3T3-L1 adipocytes. (A) Oil red O staining in 3T3-
L1 cells treated with each CL extract. The data from one representative experiment out of three are shown. (B) Intracellular triglyceride (TG)
content of the 3T3-L1 cells. Each value represents as the means ± SEM for three independent experiments. ND, non-differentiated cells. The
asterisks shows significant differences between the experimental groups, determined using Student’s t-test (*: P < 0.05, **: P < 0.01).
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by the CL hexane extract.
Effect of dietary CL on growth, serum, and liver
parameters of HFD-fed mice
Although food intake and final body weight were largely
comparable among the experimental groups, the relative
liver weights of 5% or 10% CL for the diet group were sig-
nificantly lower than those of control diet group (Table 2).
The relative weight of subcutaneous WAT was signifi-
cantly decreased and that of perirenal WAT tended to de-
crease in the 10% CL diet group compared to the control
group. No significant changes were observed in serum
levels of TG, TC, glucose, insulin and adiponectin. Serum
NEFA levels in the 10% CL diet group were significantly
lower than that in the control diet group. In accordance
with the decrease in relative liver weight (Table 2), the
hepatic TC levels of the CL diet groups were significantlylower than that of control diet group (Figure 3A). The
hepatic TG level was also significantly decreased by 10%
CL diet. A significant decrease in serum AST activity and
a decreasing tendency in serum ALT activity were ob-
served for the 10% CL diet group (Figure 3B).
Effect of dietary CL on gene expression in the WATs of
HFD-fed mice
In subcutaneous and perirenal WAT, expression of the
FASN gene was significantly reduced by both 5% and
10% CL diets (Figure 4). Similarly, the C/EBPα mRNA
levels were decreased by CL diets.
Effect of dietary CL on gene expression in the livers of
HFD-fed mice
Hepatic mRNA levels of the FASN gene were significantly
decreased in the CL diet groups (Figure 5). Significant de-
creases in HMGCR and INSIG-2a expressions were also
Figure 2 Effect of Cirsium brevicaule A. GRAY leaf (CL) hexane extract on gene expression in 3T3-L1 cells. Each value represents the
means ± S.E.M. for three independent experiments. ND, non-differentiated cells. The asterisks shows significant differences between the
experimental groups, determined using Student’s t-test (*: P < 0.05, **: P < 0.01).
Table 2 Effect of dietary CBAG leaf on growth and serum
parameters in mice
Parameters Group
Control diet 5% CL diet 10% CL diet
Food Intake (g/day) 2.25 ± 0.01 2.22 ± 0.04 2.24 ± 0.03
Initial body weight (g) 13.9 ± 0.32 13.7 ± 0.27 13.7 ± 0.28
Final body weight (g) 25.7 ± 0.43 24.8 ± 0.54 24.5 ± 0.40
Liver weight (g/100 g
body weight)
4.50 ± 0.11 3.88 ± 0.17* 3.67 ± 0.12**
White adipose tissue weight
(g/100 g body weight)
Total† 6.03 ± 0.47 5.75 ± 0.36 5.26 ± 0.28
Abdominal§ 4.34 ± 0.35 4.36 ± 0.31 4.00 ± 0.22
Epididymal 2.18 ± 0.16 2.13 ± 0.16 1.98 ± 0.11
Perirenal 0.81 ± 0.14 0.80 ± 0.07 0.64 ± 0.06
Omental 1.35 ± 0.08 1.44 ± 0.10 1.37 ± 0.08
Subcutaneous 1.69 ± 0.12 1.39 ± 0.06 1.26 ± 0.08**
Serum parameters
Triglyceride (mg/dL) 35.0 ± 3.41 40.5 ± 3.71 32.2 ± 3.10
Total cholesterol (mg/dL) 107 ± 4 107 ± 4 114 ± 3
Non-esterified fatty acid
(mEq/dL)
9.68 ± 0.89 8.41 ± 0.40 6.56 ± 0.56**
Glucose (mg/dL) 210 ± 11 242 ± 11 211 ± 25
Insulin (ng/mL) 1.70 ± 0.23 1.74 ± 0.18 1.79 ± 0.31
Adiponectin (ng/mL) 3.58 ± 0.11 3.51 ± 0.15 3.30 ± 0.13
Each value represents as the means ± S.E.M. for six mice. †Total white adipose
tissue weight represents the sum of abdominal and subcutaneous white
adipose tissue weights. §Abdominal white adipose tissue weight represents
the sum of epididymal, perirenal and omental white adipose tissue weights.
Asterisk shows significant differences when compared to the control group by
Dunnett’s test (*: P < 0.05, **: P < 0.01).
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trast, mRNA levels of CPT1A, UCP2, IR, and SREBP-2
were significantly increased by the 10% CL diet. AOX
gene expression was largely comparable among the ex-
perimental groups.
Discussion
We investigated for the first time the effects of CL extracts
on adipogenesis in adipocytes, and on the development of
obesity in B6 mice that are fed a HFD. The CL hexane ex-
tract inhibited lipid accumulation and downregulated
FASN expression in 3T3-L1 cells (Figures 1 and 2). Dietary
CL also suppressed lipid accumulation as well as FASN
mRNA levels in subcutaneous WAT and the livers of mice
fed a HFD (Table 2, Figures 4 and 5). Dietary CL, on the
other hand, increased in the hepatic mRNA levels of genes
related to β-oxidation. These results suggest that CL exerts
the antiobesity effects partly through downregulation of
fatty acid biosynthesis and enhancement of lipolysis.
FASN is highly expressed in adipose tissue and the
liver. This enzyme activity is mostly regulated at the tran-
scriptional level [21]. It has been demonstrated that FASN
inhibitors such as C75 significantly suppress the differenti-
ation and lipid accumulation in 3T3-L1 cells, which sug-
gests that FASN plays an essential role supporting the
differentiation of preadipocytes [17]. Transcription factors
such as SREBP-1c, C/EBPα, and PPARγ are known to
control the FASN expression [22,23]. In this study, the
treatment of 3T3-L1 cells with CL hexane extract signifi-
cantly decreased their TG content (Figure 1) and MEST
gene expression (Figure 2), which could be a novel marker
for adipocyte size [24]. Significant decreases in C/EBPα
and FASN gene expressions, which were observed with
Figure 3 Effect of dietary Cirsium brevicaule A. GRAY leaf (CL) on hepatic physiological parameters in mice. (A) Serum lipid levels.
(B) Serum levels of hepatopathic indicator. Each value represents the means ± S.E.M. for six mice. The asterisk shows significant differences when
compared to the control group, determined using Dunnett’s test (*: P < 0.05, **: P < 0.01).
Figure 4 Effect of dietary Cirsium brevicaule A. GRAY leaf (CL) on gene expression in the white adipose tissues of mice. Each value
represents the means ± S.E.M. for six mice. The asterisk shows significant differences when compared to the control group, determined using
Dunnett’s test (*: P < 0.05, **: P < 0.01).
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Figure 5 Effect of dietary CL Cirsium brevicaule A. GRAY leaf (CL) on the gene expression in liver of mice. Each value represents the
means ± S.E.M. for six mice. The asterisk shows significant differences when compared to the control group, determined using Dunnett’s test
(*: P < 0.05, **: P < 0.01).
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with changes in the mRNA levels of SREBP-1c as well as
PPARγ and its target gene FABP4. Dietary CL induced a
significant reduction or caused a decreasing trend in the
WAT weight of the HFD-fed mice (Table 2). Furthermore,
the expressions of FASN and C/EBPα in WATs were
significantly decreased by the CL diet (Figure 4). These
results suggest that the chemical component in CL
suppressed adipogenic differentiation or lipid accumula-
tion in adipocytes through the inhibition of FASN gene
expression via the downregulation of C/EBPα.
In humans, since exogenous saturated fatty acids are
available abundantly through the daily diet, it was con-
sidered that de novo synthesis of fatty acids was negli-
gible [25]. However, liver-selective FASN inhibition by
platensimycin could lead to improved hepatic steatosis
and T2DM in model mice [26]. This observation provided
the pharmacological proof of concept of FASN inhibition
as a unique treatment for obesity-related disorders. In this
study, significant decreases in FASN expression in WATs
and the liver were observed in the CL-fed mice (Figures 3
and 5). PPARα is well known as an indispensable regulator
of liver lipid metabolism. The key enzymes involved in
fatty acid oxidation such as CPT1A and AOX are mainly
regulated by PPARα [27,28]. Furthermore, PPARα induces
UCP2 upregulation, which is involved in the regulation of
energy expenditure [29]. The 10% CL diet significantly in-
creased the mRNA levels of PPARα, CPT1A and UCP2,
but not AOX (Figure 5). Therefore, these results suggestthat dietary CL suppressed hepatic TG content through
inhibition of FASN expression and enhancement of fatty
acid oxidation, thereby leading to significant reductions in
serum NEFA levels in the HFD-fed mice (Table 2). Plasma
NEFA levels are elevated in obesity, and a high level of
NEFA is considered a critical factor that triggers the onset
of peripheral and hepatic insulin resistance [30], eventually
leading to development of metabolic syndrome including
T2DM and NAFLD. NEFA were recently highlighted to
play primary roles in the pathogenesis of NAFLD by indu-
cing inflammation, oxidative stress, apoptosis, and cyto-
kine production in hepatocytes [31].
IR is as known as one of the most important mole-
cules involved in NEFA-induced insulin resistance, be-
cause fatty acids suppress the protein and mRNA levels
of IR in muscle cells and hepatic cells [32,33]. Although
serum insulin levels were largely comparable among the
experimental groups in the present study (Table 2), IR
gene expression was significantly increased in the liver
of mice fed the 10% CL diet (Figure 5). Yabe et al. [34]
discovered a liver-specific transcript of INSIG-2, desig-
nated INSIG-2a, which is downregulated by insulin. Our
study showed that the hepatic mRNA level of INSIG-2a
in the 10% CL diet group was significantly lower than that
in control diet group (Figure 5). Thus, dietary CL likely
functions to restore hepatic insulin sensitivities in HFD-
fed mice, preventing the development of NAFLD. In
contrast, Insigs is known to negatively regulate HMGCR
transcription by suppressing the activation of SREBPs
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esterol biosynthesis-related genes including HMGCR [36].
A significant increase in SREBP-2 gene expression was
herein observed in the livers of the 10% CL diet group
(Figure 5), although the mRNA level of HMGCR was
significantly decreased. These conflicting results need
further clarification to fully understand the anti-obesity
activity of CL.
Few studies examined the phenolic compounds in
CBAG, although various phenolic compounds have been
isolated from the genus Cirsium. Pectolinarin have been
reported as a major flavonoid in Japanese Cirsium spe-
cies [37], and it was isolated from CBAG [38]. Apigenin,
linarin, and luteorin were also isolated from a wide
variety of Cirsium species [39]. Treatment of 3T3-L1 cells
with pectolinarin were significantly increased cellular TG
content [11]. Apigenin, but not luteorin, significantly
inhibited adipogenesis in 3T3-L1 cells [40]. Although
many phenolic compounds have been reported to inhibit
lipid accumulation in 3T3-L1 cells [41], the hexane extract
of the lowest phenolic content among CL extracts herein
inhibited lipid accumulation in 3T3-L1 cells (Figure 1B
and Additional file 1: Table S2). This finding suggests that
the anti-obesity activity of CL is associated with more
hydrophobic non-phenolic compounds. Further purifica-
tion and identification of active component(s) in CL
would be necessary.
Liao et al. [11,12] reported that pectolinarin and
DDMF, which are flavonoids isolated from C. japonicum
DC, enhance adipogenic differentiation of 3T3-L1 cells
and alleviate streptozotocin-induced diabetes through
enhanced PPARγ expression and adiponectin produc-
tion. Crude extracts prepared from C. oligophyllum sig-
nificantly suppressed the lipid accumulation in WATs by
upregulating UCP1 and UCP3 expression in WATs and
skin, respectively [13]. In our present study, the hexane
extract inhibited adipocyte development and TG accu-
mulation in 3T3-L1 cells with no change in PPARγ gene
expression (Figures 1B and 2). Dietary CL reduced the
WAT weights without any changes in serum adiponectin
levels (Table 2). An inhibition of intestinal TG absorp-
tion generally decreased blood TG level, and a similar
result is observed with cholesterol [42]. In the present
study, significant decrease in serum NEFA level were
observed but not in TG and cholesterol levels of CL-fed
mice (Table 2). Therefore, the reduction in the adipose
tissue weight may be explained by the decreased endogen-
ous NEFA supply for adipogenesis and the enhancement
of fatty acid oxidation. Significant changes in the mRNA
levels of lipid metabolism-related genes and the lipid con-
tent in the livers of the CL diet group appear to support
this hypothesis. However, these data do not necessarily
negate the possibility that CL interfered the lipid absorp-
tion, and thereby exerted the anti-obesity activity as wasthe case in the previous studies. Further studies are
needed to address this question.
Conclusion
The present results clearly demonstrated the presence of
antiobesity phytochemicals in CL, thereby providing sci-
entific evidence to promote the development of natural
and safe antiobesity agents from CL. The components
in CL remains to be identified, and further studies
should be conducted to gain insights into the mechan-
ism of action of CL.
Additional file
Additional file 1: Table S1. Primer sequences for real time PCR
amplification. Table S2. Effects of Cirsium brevicaule A. GRAY leaf (CL)
extracts on lipid accumulation in 3T3-L1 adipocytes.
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